glycyl-prolyl-arginyl-proline has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies
Studies (glycyl-prolyl-arginyl-proline) | Trials (glycyl-prolyl-arginyl-proline) | Recent Studies (post-2010) (glycyl-prolyl-arginyl-proline) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
---|---|---|---|---|---|
57 | 0 | 10 | 4,832 | 294 | 150 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, MC; Huang, TF; Wang, CY | 1 |
1 other study(ies) available for glycyl-prolyl-arginyl-proline and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Ancrod-formed fibrin stimulates prostacyclin production of human umbilical vein endothelial cells via de novo synthesis of cyclooxygenase.
Topics: 6-Ketoprostaglandin F1 alpha; Ancrod; Aspirin; Blotting, Western; Cells, Cultured; Cycloheximide; Dactinomycin; Endothelium, Vascular; Epoprostenol; Fibrin; Humans; Kinetics; Oligopeptides; Prostaglandin-Endoperoxide Synthases; Umbilical Veins | 1994 |